Literature DB >> 16431105

131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands.

I S J Merkies1, G Lauria.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16431105     DOI： 10.1016/j.nmd.2005.12.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  20 in total

1.  Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND).

Authors:  Kai F Loewenbrück; Julia Liesenberg; Markus Dittrich; Jochen Schäfer; Beate Patzner; Beate Trausch; Jochen Machetanz; Andreas Hermann; Alexander Storch
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

Review 2.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

3.  Natural history of Charcot-Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life.

Authors:  Luca Padua; D Pareyson; I Aprile; T Cavallaro; D A Quattrone; N Rizzuto; G Vita; P Tonali; A Schenone
Journal:  Neurol Sci       Date:  2009-12-17       Impact factor: 3.307

Review 4.  Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard Ac Hughes; Man Mohan Mehndiratta; Yusuf A Rajabally
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

Review 5.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

6.  Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.

Authors:  Joshua Burns; Robert Ouvrier; Tim Estilow; Rosemary Shy; Matilde Laurá; Julie F Pallant; Monkol Lek; Francesco Muntoni; Mary M Reilly; Davide Pareyson; Gyula Acsadi; Michael E Shy; Richard S Finkel
Journal:  Ann Neurol       Date:  2012-05       Impact factor: 10.422

7.  Counterpoint--the end point: less is more.

Authors:  G Alexander Fleming
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

8.  Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study.

Authors:  L Padua; I Aprile; T Cavallaro; I Commodari; D Pareyson; A Quattrone; N Rizzuto; G Vita; P Tonali; A Schenone
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

Review 9.  Treatment for IgG and IgA paraproteinaemic neuropathy.

Authors:  Abraham C J Stork; Michael P T Lunn; Eduardo Nobile-Orazio; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2015-03-24

10.  Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome.

Authors:  Nora A Visser; Alexander F J E Vrancken; Yvonne T van der Schouw; Leonard H van den Berg; Nicolette C Notermans
Journal:  Diabetes Care       Date:  2012-11-30       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.